ly 274614 has been researched along with Disease Models, Animal in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Coimbra, NC; de Freitas, RL; de Oliveira Silva, M; Machado, HR; Malvestio, RB; Medeiros, AC; Medeiros, P; Negrini-Ferrari, SE | 1 |
| Gewirtz, JC; Rothwell, PE; Thomas, MJ | 1 |
| Balter, RE; Dykstra, LA; Fischer, BD; Henry, FE; Miller, LL; Schmidt, KT | 1 |
| Bicca, MA; Bouzon, ZL; Calixto, JB; Figueiredo, CP; Medeiros, R; Meotti, FC; Piermartiri, TC; Tasca, CI | 1 |
| Borowicz, KK; Czuczwar, SJ; Gasior, M; Kleinrok, Z | 1 |
| Joyner, PW; McMillen, BA; Parmar, CA; Tyer, WE; Williams, HL | 1 |
7 other study(ies) available for ly 274614 and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
The primary motor cortex electrical and chemical stimulation attenuates the chronic neuropathic pain by activation of the periaqueductal grey matter: The role of NMDA receptors.
Topics: Analgesia; Animals; Chronic Pain; Deep Brain Stimulation; Disease Models, Animal; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Isoquinolines; Male; Motor Cortex; Neuralgia; Periaqueductal Gray; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 2021 |
Distinct profiles of anxiety and dysphoria during spontaneous withdrawal from acute morphine exposure.
Topics: Acoustic Stimulation; Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Chlordiazepoxide; Conditioning, Operant; Depression; Disease Models, Animal; Excitatory Amino Acid Antagonists; Isoquinolines; Male; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Propranolol; Rats; Rats, Sprague-Dawley; Reflex, Startle; Substance Withdrawal Syndrome; Time Factors | 2009 |
Opioid antinociception, tolerance and dependence: interactions with the N-methyl-D-aspartate system in mice.
Topics: Analgesics, Opioid; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Tolerance; Excitatory Amino Acid Antagonists; Gene Knockdown Techniques; Isoquinolines; Male; Mice; Morphine; Morphine Dependence; Pain; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid, mu | 2011 |
The selective and competitive N-methyl-D-aspartate receptor antagonist, (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid, prevents synaptic toxicity induced by amyloid-β in mice.
Topics: Alzheimer Disease; Amino Acid Transport System X-AG; Amyloid beta-Peptides; Animals; Disease Models, Animal; Excitatory Amino Acid Antagonists; Humans; Immunohistochemistry; Isoquinolines; Male; Mice; Reactive Oxygen Species; Receptors, N-Methyl-D-Aspartate; Synapses; Synaptophysin | 2011 |
Competitive NMDA-receptor antagonists, LY 235959 and LY 233053, enhance the protective efficacy of various antiepileptic drugs against maximal electroshock-induced seizures in mice.
Topics: Animals; Anticonvulsants; Avoidance Learning; Disease Models, Animal; Drug Synergism; Electroshock; Epilepsy; Excitatory Amino Acid Antagonists; Female; Humans; Isoquinolines; Kindling, Neurologic; Memory; Mice; Motor Activity; Pipecolic Acids; Receptors, N-Methyl-D-Aspartate; Seizures; Tetrazoles | 1996 |
Effects of NMDA glutamate receptor antagonist drugs on the volitional consumption of ethanol by a genetic drinking rat.
Topics: Alcohol Drinking; Alcohol-Induced Disorders, Nervous System; Alcoholism; Amino Acids, Cyclic; Animals; Brain; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Ethanol; Excitatory Amino Acid Antagonists; Female; Genetic Predisposition to Disease; Glutamic Acid; Isoquinolines; Male; Motor Activity; Pyrrolidinones; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission; Volition | 2004 |